ScholarIQanswers from OpenAlex

High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma

PaperCitations, authors & open-access status

High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma have?

ScholarIQcitation count

High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma has 53 citations in the OpenAlex counts ScholarIQ stores.

When was High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma published?

ScholarIQyear

High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma has 2019 year in the ScholarIQ index.

What is the open-access status of High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma?

ScholarIQoa status

High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma has diamond oa status in the ScholarIQ index.

What is the DOI of High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma?

ScholarIQdoi

The DOI for High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma is on the source record.

What is the PMID of High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma?

ScholarIQpmid

The PMID for High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma is on the source record.

What is the OpenAlex record for High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma?

ScholarIQopenalex

The OpenAlex for High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial